Polyphenol fraction of extra virgin olive oil protects against endothelial dysfunction induced by high glucose and free fatty acids through modulation of nitric oxide and endothelin-1  by Storniolo, Carolina Emilia et al.
Redox Biology 2 (2014) 971–977Contents lists available at ScienceDirectRedox Biologyhttp://d
2213-23
Abbre
FFAs, fre
diamino
droﬂuor
activate
PI3K, ph
MEDiter
n Corr
E-mjournal homepage: www.elsevier.com/locate/redoxResearch PaperPolyphenol fraction of extra virgin olive oil protects against endothelial
dysfunction induced by high glucose and free fatty acids through
modulation of nitric oxide and endothelin-1
Carolina Emilia Storniolo a, Joan Roselló-Catafau b, Xavier Pintó c, María Teresa Mitjavila d,
Juan José Moreno a,n
a Department of Physiology, Faculty of Pharmacy, University of Barcelona, Avda. Joan XXIII s/n, Barcelona E-08028, Spain
b Department of Experimental Pathology, IIBB-CSIC, IDIBAPS, Barcelona E-08036, Spain
c Lipids and Vascular Risk Unit, Internal Medicine, University Hospital of Bellvitge, Hospitalet de Llobregat, Barcelona E-08907, Spain
d Department of Physiology and Immunology, Faculty of Biology, University of Barcelona, Avda. Diagonal 485, Barcelona E-08028, Spaina r t i c l e i n f o
Article history:
Received 11 June 2014
Received in revised form
9 July 2014
Accepted 14 July 2014
Available online 21 July 2014
Keywords:
Type 2 diabetes
Hyperglycemia
Oleic acid
Linoleic acid
ECV304 cells
Reactive oxygen species
Cell oxidative stressx.doi.org/10.1016/j.redox.2014.07.001
17/& 2014 The Authors. Published by Elsevier
viations: ; EVOO, extra virgin olive oil; NO, nit
e fatty acids; ROS, reactive oxygen species; Ac
ﬂuorescein diacetate; CM-H2DCF-DA, 5,6-chlo
escein diacetate; eNOS, endothelial nitric oxid
d protein kinase; PEEVOO, polyphenol extract
osphoinositide 3-kinase; PREDIMED, The PRE
ranea
esponding author.
ail address: jjmoreno@ub.edu (J.J. Moreno).a b s t r a c t
Epidemiological and clinical studies have reported that olive oil reduces the incidence of cardiovascular
disease. However, the mechanisms involved in this beneﬁcial effect have not been delineated. The
endothelium plays an important role in blood pressure regulation through the release of potent
vasodilator and vasoconstrictor agents such as nitric oxide (NO) and endothelin-1 (ET-1), respectively,
events that are disrupted in type 2 diabetes. Extra virgin olive oil contains polyphenols, compounds that
exert a biological action on endothelial function. This study analyzes the effects of olive oil polyphenols
on endothelial dysfunction using an in vitro model that simulates the conditions of type 2 diabetes. Our
ﬁndings show that high glucose and linoleic and oleic acids decrease endothelial NO synthase
phosphorylation, and consequently intracellular NO levels, and increase ET-1 synthesis by ECV304 cells.
These effects may be related to the stimulation of reactive oxygen species production in these
experimental conditions. Hydroxytyrosol and the polyphenol extract from extra virgin olive oil partially
reversed the above events. Moreover, we observed that high glucose and free fatty acids reduced NO and
increased ET-1 levels induced by acetylcholine through the modulation of intracellular calcium
concentrations and endothelial NO synthase phosphorylation, events also reverted by hydroxytyrosol
and polyphenol extract. Thus, our results suggest a protective effect of olive oil polyphenols on
endothelial dysfunction induced by hyperglycemia and free fatty acids.
& 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).Introduction
Epidemiological studies of the dietary patterns of Mediterra-
nean countries have demonstrated that olive oil consumption
lowers the incidence of cardiovascular disease [1,2] and that olive
oil is associated with lower blood pressure [3]. The PREvencion
con DIeta MEDiterranea (PREDIMED) study is a large-scale,B.V. This is an open access article u
ric oxide; ET-1, endothelin-1;
h, acetylcholine; DAF-DA, 4,5-
romethyl 2′,7′-dichlorodihy-
e synthase; MAPK, mitogen-
from extra virgin olive oil;
vention con DIetamulticenter, randomized trial that observed that the traditional
Mediterranean diet enriched with extra virgin olive oil (EVOO)
reduced the incidence of cardiovascular events in high-risk pa-
tients [4]. The results of the 3-month intervention on the ﬁrst 772
patients entering the study showed that, compared with a low-fat
diet, the Mediterranean diet rich in EVOO reduced blood pressure
in a hypertensive population [5]. This ﬁnding was also observed in
a 4-year follow-up study [6]. However, the mechanisms involved
in this beneﬁcial effect on the blood pressure have not been
delineated. We must consider that minor compounds, such as
polyphenols, which constitute the unsaponiﬁable fraction of EVOO
prevent autooxidation of the oil, contribute to its characteristic
ﬂavor and taste, and are responsible, at least in part, for their
beneﬁcial effects.
Endothelium plays an important role in the regulation of
vascular tone via the synthesis and release of vascular modulatorsnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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1 (ET-1), a vasoconstrictor agent [8] that acts as the natural
counterpart to endothelium-derived NO [9]. An imbalance be-
tween these vasoactive molecules results in endothelial
dysfunction.
Endothelium-dependent vascular relaxation is impaired in
diabetes [10]. Insulin resistance is known to be associated with
increased plasma levels of free fatty acids (FFAs), a consequence of
hyperglycemia [11]. An increase in FFAs is likely to contribute to
functional and structural vascular changes through vascular NO/
ET-1 levels [12]. Moreover, hyperglycemia and FFAs cause an
excessive formation of reactive oxygen species (ROS), including
superoxide anion which reacts with NO to generate peroxynitrite.
Very little research on the mechanisms underlying the modulation
of endothelial dysfunction induced by FFAs in type 2 diabetes has
been conducted. This study was designed to elucidate the effects
of EVOO polyphenols on NO/ET-1 synthesized by endothelial cells
in in vitro experimental conditions that simulated type 2 diabetes
(high glucose and elevated FFAs) in the culture medium to
understand the effects of polyphenols on cell signaling as well as
the mechanisms involved in endothelial homeostasis.Materials and methods
Materials
Cell culture medium, heat-inactivated fetal bovine serum,
penicillin G, streptomycin and trypsin/EDTA were supplied by
Bio Whittaker Europe (Verviers, Belgium). Aprotinin, phenyl-
methylsulfonyl ﬂuoride, leupeptin, dimethyldithiocarbamic acid,
β-sitosterol from soya beans, oleic and linoleic acids, acetylcholine
(Ach) chloride, 4,5-diaminoﬂuorescein diacetate (DAF-DA), PD
98059, SB 202190, wortmannin, Fura-2AM, superoxide dismutase
(SOD) and catalase from human erythrocytes were obtained from
Sigma Chem. Co. (St. Louis, MO, USA). 5,6 Chloromethyl 2′,7′-
dichlorodihydroﬂuorescein diacetate (CM-H2DCF-DA) was ob-
tained from Invitrogen SA (Barcelona, Spain). Hydroxytyrosol and
bovine recombinant endothelial NO synthase (eNOS) were sup-
plied by Cayman Chem. Co. (Ann Arbor, MI, USA). Apocynin came
from Calbiochem (Darmstadt, Germany). All other chemicals were
of the highest quality commercially available. Oleic and linoleic
acids were dissolved in 0.1 M NaOH at 70 °C and then complexed
with 10% BSA at 55 °C for 10 min. These stock solutions of 5 mM
FFAs were prepared the day before the experiment, placed in a
sealed tube in nitrogen atmosphere and stored overnight at
20 °C, then added to the cell culture medium. A solution with
10% BSA was added to control cultures.
Polyphenols present in EVOO were extracted three times with
80% methanol (1/1, vol/vol). The methanolic extract was evapo-
rated under vacuum in a nitrogen ﬂow, and the total polyphenol
concentration in the aqueous extract was determined [13]. Total
polyphenols were expressed as mg gallic acid equivalents. Our
samples had a total polyphenol content of 7673 mg gallic acid
equivalents/kg olive oil. Polyphenol extract from EVOO (PEEVOO)
was prepared to 0.5 mM gallic acid equivalents.
Cells and cell culture
ECV304 cells have been considered as endothelial like cells.
They were obtained from the European Collection of Cell Cultures
(Salisbury, UK) and grown in medium 199 with Earl’s salts, 25 mM
HEPES supplemented with 2 mM L-glutamine, 100 U/ml penicillin,
100 mg/ml streptomycin, and 10% FBS. Cells were split at con-
ﬂuence 1–3 or at higher passages 1–2 every 5–7 days and plated
on gelatin-coated ﬂasks up to passage 20 [14]. ECV304 cells werewashed and incubated in normal glucose (5 mM glucose and
25 mM mannitol as an osmotic control of high glucose) or co-
incubated with high glucose (30 mM) in the presence or absence
of 0–120 mM FFAs (oleic or linoleic acid) and 10 mM hydroxytyrosol
or 10 mM gallic acid equivalents of PEEVOO for 48 h.
Intracellular reactive oxygen species generation
Cells were rinsed twice with PBS supplemented with 5 mM
glucose and 5 mM HEPES. Intracellular ROS were detected once
1 mM CM-H2DCF-DA was oxidized to a ﬂuorescent DCF product
within the cell after incubation at 37 °C for 20 min. We performed
the experiments in the presence of SOD or catalase to conﬁrm that
CM-H2DCF-DA probe measure ROS in our experimental conditions
[15]. The ﬂuorescence intensity was analyzed using a FLUOstar
OPTIMA ﬂuorometer (BMG Labtech, Ortenburg, Germany), with
excitation at 495 nm and emission at 515 nm.
Intracellular nitric oxide generation
Cells were rinsed with PBS and incubated with 10 mM DAF-DA
for 10 min. at 37 °C. Intracellular basal NO production and NO
production in response to 10 mM Ach were measured by the level
of change in ﬂuorescence intensity (DAF-2T), which was detected
under the FLUOstar OPTIMA ﬂuorometer (BMG Labtech, Orten-
burg, Germany), with excitation at 495 nm and emission at
515 nm. The real-time changes in intracellular ﬂuorescence in-
tensity were measured for 15 min. There are some pitfalls and
limitation for using DAF-DA to measure NO concentrations. The
intermediate probe DAF-2 is autoﬂuorescence [16]. For this reason
we always perform the experiments in the dark and we express
the results by the ﬂuorescence relative intensity (F1/F0) before and
after the addition of Ach.
To investigate the role of phosphoinositide 3-kinase (PI3K/Akt)
and mitogen-activated protein kinase (MAPK) (ERK and p38)
signaling cascades on the effects of olive oil polyphenols on NO
synthesized by ECV304 cells, we used Akt, ERK or p38 speciﬁc
inhibitors such as wortmannin [17], PD98059 [18] and SB202190
[19], respectively.
Intracellular calcium concentration
ECV304 cells grown in clusters were loaded with 25 mM Fura-
2AM (a selective ﬂuorescent Ca2þ indicator) in DMEM for 1 h at
37 °C as we previously described [20]. Cells were stimulated with
10 mM Ach and [Ca2þ]i was calculated in accordance with Gryn-
kiewicz et al. [21].
Western blot analysis of endothelial nitric oxide synthase
ECV304 cells were washed twice in ice-cold PBS, scraped off
into PBS containing 2 mM EDTA and pelleted. Cell pellets were
sonicated in PBS containing 2 mM EDTA, 2 mg/ml phenylmethyl-
sulfonyl ﬂuoride, 20 mg/ml aprotinin, 20 mg/ml leupeptin and
200 mg/ml dimethyldithiocarbamic acid, separated by SDS-PAGE
and blotted onto a nitrocellulose membrane using a Mini-Protean
II system (Bio-Rad, Hercules, CA, USA). Finally, the membranes
were blocked and eNOS or phospho-eNOS (Ser 1107)
were immunodetected using rabbit polyclonal antiserums
(Cayman Chem. Co., Ann Arbor, MI, USA and Cell Signaling,
Beverly, MA, USA, respectively) in a 1/2000 dilution for 1 h.
All blots were developed using an enhanced chemiluminescence
kit (Supersignal West Dura Extended Duration Substrate) from
Pierce (Rockford, IL, USA).
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ET-1 concentrations in supernatant cell cultures were analyzed
by enzyme immunoassay (R&D Systems, Minneapolis, MN, USA).
The minimum detectable concentration of ET-1 was 0.02–0.03 pg/
ml. The inter-assay and intra-assay coefﬁcient of variation were
4.5% and 2.6%, respectively.
Statistical analysis
Results were expressed as mean7SEM. Statistical evaluation of
the data was performed by Wilcoxon and Mann–Whitney test.
Values were considered to be statistically different at po0.05.Results
Incubation of ECV304 cells with growing concentrations of
oleic and linoleic acids lowered intracellular NO levels (Fig. 1A)
and increased ROS (Fig. 1B). Interestingly, these changes were less
marked in the presence of oleic acid. These effects wereFig. 1. Effect of oleic and linoleic acids on nitric oxide (NO) and reactive oxygen
species (ROS) produced by ECV304 cells. Cells were cultured in 199 medium and
10% FBS for 48 h with oleic (triangle) or linoleic (romb) acid (0–120 mM). NO (A) and
ROS (B) levels were measured using DAF-DA or CM-H2DCF-DA, respectively. Results
are means7SEM of at least three experiments performed in triplicate. *po0.05 vs
control cells. The changes in endothelial NO synthase (eNOS) and phosphorylated
eNOS (p-eNOS) in the presence of oleic or linoleic acid (60 mM) were measured by
Western blot. A representative blot (C) and the means of three blots (D) are shown.
Fig. 2. Effect of hydroxytyrosol (HT) and polyphenol extract from extra virgin olive
oil (PEEVOO) on the changes in nitric oxide (NO), reactive oxygen species (ROS) and
endothelin-1 (ET-1) induced by the presence of high glucose (HG) and/or linoleic
and oleic acids in ECV304 cells. Cells were cultured in 199 medium and 10% FBS for
48 h in normal glucose (NG, 5 mM), HG (30 mM) or HG together with linoleic or
oleic acid (60 mM) in the presence or absence of HT (10 mM) or PEEVOO (10 mM
gallic acid equivalents). NO (A), ROS (B) and ET-1 (C) concentrations in the culture
supernatants were determined. Results are means7SEM of at least three experi-
ments performed in triplicate. *po0.05 vs control cells; ‡ po0.05 vs HG condition;
† po0.05 vs HG plus linoleic acid; # po0.05 vs HG plus oleic acid.concentration-dependent and reached signiﬁcant changes up to
40 mM FFAs. The impairment of NO concentrations induced by
linoleic and oleic acids may be related to a reduction in eNOS
phosphorylation as shown in Fig. 1C. High glucose concentration
also signiﬁcantly decreased intracellular NO concentration (22%) in
the ECV304 cell culture (Fig. 2A), whereas it markedly enhanced
ROS formation (110%) (Fig. 2B) and ET-1 concentration (95%)
(Fig. 2C). The change in NO bioavailability by high glucose may
be related to a reduction in eNOS phosphorylation (Fig. 3).
Fig. 3. Effect of hydroxytyrosol (HT) and polyphenol extract from extra virgin olive
oil (PEEVOO) on endothelial nitric oxide synthase (eNOS) phosphorylation induced
by high glucose (HG) and oleic acid. ECV304 cells were cultured in 199 medium and
10% FBS for 48 h in normal glucose (NG, 5 mM), HG (30 mM) or HG together with
oleic acid (60 mM) in the presence or absence of HT (10 mM) or PEEVOO (10 mM
gallic acid equivalents). Cells were scraped off and eNOS and p-eNOS were
determined by Western blot. A representative blot (A) and means from three
westerns blots (B) are shown. Bars are means7SEM. *po0.05 vs control cells; ‡
po0.05 vs HG plus oleic acid.
Fig. 4. Effect of hydroxytyrosol (HT) and polyphenol extract from extra virgin olive
oil (PEEVOO) on the changes in nitric oxide (NO) and intracellular calcium
concentration ([Ca2þ]i) induced by acetylcholine (Ach) in the presence of high
glucose (HG) and/or oleic and linoleic acids in ECV304 cells. Cells were cultured in
199 medium and 10% FBS for 48 h in normal glucose (NG, 5 mM), HG (30 mM) or
HG together with linoleic or oleic acid (60 mM) in the presence or absence of HT
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ROS and ET-1 in ECV304 cells induced by high glucose levels were
heightened by the presence of 60 mM FFAs, and the effect of
linoleic acid was higher than that of oleic acid (Fig. 2A–C). Our
ﬁndings also show that the NADPH oxidase inhibitor apocynin [22]
and antioxidant enzymes such as SOD and catalase reversed the
impairment of NO levels induced by high glucose/oleic acid
(Table 1).Table 1
Effect of NADPH, Akt, ERK and p38 inhibitors on nitric oxide concentrations in the
experimental conditions of the present study.
DAF-DA ﬂuorescence (F1/F0)
NG 1.0570.03
HG 0.7370.05*
HGþoleic acid 0.5870.04*
HGþoleic acidþapocynin (100 mM) 0.6970.03#
HGþoleic acidþSOD (50 units/ml) 0.7470.03#
HGþoleic acidþcatalase (100 units/ml) 0.7170.02#
HGþoleic acidþHT 0.7570.05#
HGþoleic acidþHTþwortmannin (5 mM) 0.6570.02†
HGþoleic acidþHTþPD 98059 (10 mM) 0.7270.04
HGþoleic acidþHTþSB 202190 (1 mM) 0.7170.03
HGþoleic acidþHTþPD 98059þSB 202190 0.6270.02†
HGþoleic acidþPEEVOO 0.8270.03#
HGþoleic acidþPEEVOOþwortmannin (5 mM) 0.6770.02†
HGþoleic acidþPEEVOOþPD 98059 (10 mM) 0.7870.03
HGþoleic acidþPEEVOOþSB202190 (1 mM) 0.7770.04
HGþoleic acidþPEEVOOþPD 98059þSB 202190 0.6070.04†
Data are expressed as means7SEM from three independent experiments per-
formed in duplicate.
n po0.05 vs normal glucose (NG).
# po0.05 vs high glucose (HG) plus oleic acid.
† po0.05 vs HG plus oleic acid plus hydroxytyrosol (HT) or polyphenol extract
from extra virgin olive oil (PEEVOO).
(10 mM) or PEEVOO (10 mM gallic acid equivalents). Ach (0.1 mM) was added and NO
concentration (A) and [Ca2þ]i (B) were determined. Results are means7SEM of at
least three experiments performed in triplicate. *po0.05 vs control cells; ‡ po0.05
vs HG condition; † po0.05 vs HG/linoleic acid; # po0.05 vs HG/oleic acid.Ach induced an increase in intracellular NO production in
endothelial ECV304 cells, as well as [Ca2þ]i (Fig. 4). Our results
also demonstrate that 30 mM glucose lessened the enhancement
of NO production and [Ca2þ]i induced by Ach (Fig. 4).
Hydroxytyrosol and PEEVOO prevented the reduction in NO
(Fig. 2A), the increase in ROS (Fig. 2B) and ET-1 (Fig. 2C) induced by
high glucose and elevated FFA concentrations. Moreover, we
observed that the reversal of the NO production impairment
induced by hydroxytyrosol and PEEVOO (Fig. 2B) was related to
the phosphorylation of eNOS in these experimental conditions
(Fig. 3) and that both treatments blocked the reduction induced by
high glucose/FFAs on NO and [Ca2þ]i and production stimulated by
Ach (Fig. 4). As reported in Table 1, the inhibition of PI3K/Akt, ERK
and p38 by 5 mM wortmannin, 10 mM PD98059 and 1 mM
SB202190, respectively, blocked the beneﬁcial action of hydroxy-
tyrosol or PEEVOO on the change in NO levels induced by high
glucose/oleic acid.
Discussion
There is now compelling evidence that there are subtle altera-
tions in the endothelium in the early stages of atherogenesis. This
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a decline in the bioavailability of NO as a consequence of reduced
biosynthesis and/or increased degradation. Moreover, longitudinal
studies have shown that impaired NO dependent vasodilation can
predict arterial hypertension risk, future cardiac events [23] and
the development of coronary artery disease [24].
Several authors have reported that FFAs such as oleic and
linoleic acids reduce the levels of intracellular NO synthesized by
endothelial cells [25,26]. Our data conﬁrm that linoleic and oleic
acids at concentrations reached in human plasma [27] markedly
reduce NO levels, and the effect of linoleic acid was higher than
that of oleic acid. This effect of the FFAs studied may be related to
the enhancement of ROS also observed by Du et al. [28] and
attributed to FFAs-induced overproduction of superoxide by the
mitochondrial electron transport chain. However, our ﬁndings also
suggest that NA(D)PH oxidases are involved as it was previously
observed in mice with type 2 diabetes [29], a disorder in which
ROS derived from these oxidases play a key role in vascular
endothelial dysfunction [30]. We demonstrate that the NAD(P)H
inhibitor apocynin, SOD and catalase effectively reversed the
intracellular NO impairment induced by high glucose/oleic acid,
which would indicate the involvement of ROS produced by NAD(P)
H oxidases. However, we must consider that Heumüller et al. [31]
reported that apocynin predominantly acts as an antioxidant in
endothelial cells but not as NADPH oxidase inhibitor. The present
results are also consistent with reports on the overexpression of
NAD(P)H elements in high glucose-stimulated ROS generation in
endothelial cells [30,32] and in diabetic rat arteries [33].
Stress is known to elevate the expression of certain genes in
several cell types including endothelial and smooth muscle cells
[34]. Furthermore, hyperglycemia increases ROS production, PKC
activity, and advanced glycation end-product formation which are
known to inhibit the PI3K/Akt/eNOS pathway [35], decrease NO
bioavailability [36] and increase ET-1 plasma concentrations [37].
Considering all together, we examined the simultaneous effects of
oleic or linoleic acid and high glucose concentration on NO
production and ET-1 release by ECV304 cell cultures. Our ﬁndings
show that these experimental conditions, which simulate those of
type 2 diabetes, induce endothelial dysfunction through the
impairment of NO caused by the reduction in eNOS phosphoryla-
tion and the enhancement of ET-1, related to oxidative stress.
The PREDIMED study recently showed that EVOO consumption
led to a reduction in the blood pressure of elderly Mediterranean
participants with high risk for cardiovascular disease [6,38].
However, there is little information concerning the EVOO compo-
nents in its beneﬁcial effects and the mechanisms involved. In
Mediterranean countries, the main dietary source of polyphenols
is coffee and fruits, and the most important differentiating factor
with respect to other countries is the consumption of polyphenols
from olives and olive oil [39]. Nicholson et al. [40] reported that
physiological concentrations of dietary polyphenols increased
basal eNOS expression and lowered ROS-induced ET-1 mRNA
expression. For the ﬁrst time, we demonstrated that olive oil
polyphenol concentration reached in plasma following olive oil
consumption [41] may prevent, at least in part, the effects of high
glucose/FFAs on basal NO/ET-1 levels in endothelial cell cultures.
eNOS is a constitutively expressed enzyme, controlled at
transcriptional and post-transcriptional level [42]. The post-tran-
scriptional regulation of eNOS is dependent on the phosphoryla-
tion state, substrate and cofactor availability, endogenous inhibi-
tors (caveolins) as well as calcium. eNOS can be phosphorylated on
serine, threonine, and tyrosine residues but the most functional
changes are a consequence of Ser 1177 phosphorylation [43]. The
notion of disrupted insulin signaling via impaired PI3K/Akt/eNOS
phosphorylation, as the major determinant of decreased NO and
endothelial dysfunction, has been challenged [11]. In this regard,polyphenol-induced NO formation is due to the redox-sensitive
activation of the PI3K/Akt pathway, which leads to eNOS activation
subsequent to its phosphorylation on Ser 1177 [44] as observed
with polyphenolic-rich fraction of black tea [45] through the
estrogen receptor dependent pathway [46]. The present study
demonstrates for the ﬁrst time that olive oil polyphenols such as
hydroxytyrosol stimulate eNOS activity, primarily through non-
genomic activation in endothelial cells. New ﬁndings have shown
the importance of crosstalk between PI3K/Akt and MAPK path-
ways. The regulatory interaction between components of Akt and
MAPK cascades and NO synthesis by endothelial cells has been
well documented [47]. Our results show that Akt, ERK and p38
may be involved in eNOS phosphorylation induced by olive oil
polyphenols.
We observed that high glucose and FFAs decrease NO bioavail-
ability induced by Ach and that olive oil polyphenols can sig-
niﬁcantly impede this action. Thus, a polyphenol extract from red
wine signiﬁcantly increased [Ca2þ]i which led to the endothelial
formation of NO [48]. We observed a similar effect induced by
olive oil polyphenols on [Ca2þ]i and NO synthesis stimulated by
Ach. It is likely that olive oil polyphenols modulate NO production
through the control of Ser 1177 eNOS phosphorylation and
changes in [Ca2þ]i.
In conclusion, the present study provides new evidences that
hydroxytyrosol and PEEVOO reduce the oxidative stress and
modulate NO and ET-1 in experimental conditions that simulated
hyperglycemia and high FFA levels observed in diabetes. These
ﬁndings suggest that EVOO is potentially more effective than high
oleic seed oils, which do not contain polyphenols, in the dietary
treatment of physiopathological events involved in endothelial
dysfunction. Although, numerous studies including morphological,
cytochemical and genetic analyzes validated ECV304 as an en-
dothelial cell model, several differences between ECV304 and
human endothelial cells are reported [49]. It should be necessary
to conﬁrm our results using umbilical vein endothelial cells.Acknowledgments
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